Safety of Intra-articular Hyaluronic Acid Injections in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis.
Germain HonvoJean-Yves ReginsterFrancois RannouXavier RygaertAnton GeerinckVéronique RabendaTim McAlindonAlexia CharlesNicholas FuggleCyrus CooperElizabeth CurtisNigel ArdenBernard AvouacOlivier BruyèrePublished in: Drugs & aging (2019)
Using the available data on studies without any concomitant anti-OA medication permitted during clinical trials, IAHA seems not to be associated with any safety issue in the management of OA. However, this evidence was associated with only a "low" to "moderate" certainty. A possible association with increased risk of serious AEs, particularly when used with concomitant OA medications, requires further investigation.
Keyphrases
- hyaluronic acid
- knee osteoarthritis
- clinical trial
- healthcare
- rheumatoid arthritis
- electronic health record
- high intensity
- big data
- emergency department
- ultrasound guided
- randomized controlled trial
- metabolic syndrome
- type diabetes
- adipose tissue
- platelet rich plasma
- phase ii
- case control
- weight loss
- glycemic control